Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice

Prognostic gene expression profiling (GEP) tests for cutaneous melanoma (CM) are not recommended in current guidelines outside of a clinical trial. However, their use is becoming more prevalent and some practitioners are using GEP tests to guide patient management. Thus, there is an urgent need to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossman, Douglas, Kim, Caroline C, Hartman, Rebecca I, Berry, Elizabeth, Nelson, Kelly C, Okwundu, Nwanneka, Curiel-Lewandrowski, Clara, Leachman, Sancy A, Swetter, Susan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920745/
https://www.ncbi.nlm.nih.gov/pubmed/31871621
http://dx.doi.org/10.2217/mmt-2019-0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920745/
https://www.ncbi.nlm.nih.gov/pubmed/31871621
http://dx.doi.org/10.2217/mmt-2019-0016

Ejemplares similares